Analysis of the association between APOA5 polymorphism and cholesterol lowering effects among statin users with hypercholesterolemia from HUSM, Kelantan
Statins, HMG-CoA reductase inhibitors, have shown their efficacy in reducing one of the major risk factors for the disease i.e., the plasma cholesterol level. Patients’ responses to statin therapy have, however, been found to vary significantly. The interindividual variation can be attributed to...
Saved in:
Main Author: | Tounbakjy, Mhd Houssam Iyad |
---|---|
Format: | Thesis |
Language: | English |
Published: |
2020
|
Subjects: | |
Online Access: | http://eprints.usm.my/47983/1/26.%20Thesis_Final%20Copy_THESIS_MHD%20HOUSSAM%20TOUNBAKJY_P-SKM0055_19-24%20pages.pdf http://eprints.usm.my/47983/ |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Analysis of the association between cetp taq1B polymorphism (rs708272) and cholesterol lowering effects among statin users with hyperlipidaemia from HUSM : a pilot study
by: Rahman, Ilani Ab
Published: (2018) -
Analysis of the association between SLCO1B1 genetic polymorphism (rs4149056) and lipid profile among statin users of HUSM, Kelantan
by: Yusri, Nur Farah Izzati
Published: (2022) -
Association of genetic polymorphisms and their attributing factors with lipid profiles among outpatient statin users in Hospital USM
by: Shamsudin, Amirul Faez
Published: (2022) -
The family's role in assisting hypercholesterolemia individuals to controlling serum cholesterol level
by: Saryono bin Tujin Dimyati,
Published: (2011) -
The impact of APOA5, APOB, APOC3 and ABCA1 gene polymorphisms on ischemic stroke: Evidence from a meta-analysis
by: Au, A., et al.
Published: (2017)